ArticleScientific reports2026

Phase 1 dose-finding study of topical neostigmine ophthalmic solution for alleviating myasthenic ptosis.

Chuthamas Ongprakobkul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.